Peter Blume-Jensen

Companies

• Acrivon Therapeutics, Inc.Board member Nov 9, 2022 to now¹
• Acrivon Therapeutics, Inc.Chief executive officer Nov 9, 2022 to now¹
• Acrivon Therapeutics, Inc.President Nov 9, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ATAcrivon Therapeutics, Inc. ACRV2,615,911 shares²$4.4M at $1.70Aug 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 25, 2026Sold 14,036 shares at $2.21 of Acrivon Therapeutics, Inc.²
• May 18, 2026Granted 72,706 shares of Acrivon Therapeutics, Inc.³
• May 18, 2026Granted 180,095 shares of Acrivon Therapeutics, Inc.³
• May 14, 2026Shares withheld for tax 490 shares at $1.92 of Acrivon Therapeutics, Inc.⁴
• May 14, 2026Shares withheld for tax 1,253 shares at $1.92 of Acrivon Therapeutics, Inc.⁴
• Feb 21, 2026Shares withheld for tax 14,265 shares at $1.53 of Acrivon Therapeutics, Inc.⁵
• Feb 14, 2026Shares withheld for tax 579 shares at $1.63 of Acrivon Therapeutics, Inc.⁶
• Feb 14, 2026Shares withheld for tax 1,302 shares at $1.63 of Acrivon Therapeutics, Inc.⁶
• Jan 14, 2026Bought 49,000 shares at $1.68 of Acrivon Therapeutics, Inc.⁷
• May 21, 2025Shares withheld for tax 19,904 shares at $1.15 of Acrivon Therapeutics, Inc.⁸
• May 14, 2025Shares withheld for tax 491 shares at $1.14 of Acrivon Therapeutics, Inc.⁹
• May 14, 2025Shares withheld for tax 59,766 shares at $1.14 of Acrivon Therapeutics, Inc.⁹
• Feb 21, 2025Shares withheld for tax 19,904 shares at $5.54 of Acrivon Therapeutics, Inc.¹⁰
• Nov 14, 2024Shares withheld for tax 490 shares at $7.92 of Acrivon Therapeutics, Inc.¹¹
• Nov 14, 2024Shares withheld for tax 59,766 shares at $7.92 of Acrivon Therapeutics, Inc.¹¹
• Aug 21, 2024Shares withheld for tax 79,616 shares at $9.19 of Acrivon Therapeutics, Inc.¹²
• Aug 14, 2024Shares withheld for tax 59,765 shares at $7.02 of Acrivon Therapeutics, Inc.¹³
• May 14, 2024Shares withheld for tax 54,918 shares at $8.36 of Acrivon Therapeutics, Inc.¹⁴
• Feb 14, 2024Shares withheld for tax 41,861 shares at $3.40 of Acrivon Therapeutics, Inc.¹⁵
• Nov 14, 2023Shares withheld for tax 239,023 shares at $5.08 of Acrivon Therapeutics, Inc.¹⁶
• Aug 21, 2023Granted 493,994 shares of Acrivon Therapeutics, Inc.¹⁷
• May 31, 2023Exercised options 33,605 shares at $3.88 of Acrivon Therapeutics, Inc.¹⁸
• Nov 14, 2022Granted 26,707 shares of Acrivon Therapeutics, Inc.¹⁹
• Nov 14, 2022Granted 60,090 shares of Acrivon Therapeutics, Inc.¹⁹
• Nov 14, 2022Granted 503,419 shares of Acrivon Therapeutics, Inc.¹⁹